Gene_set	Pathway	Overlap	P-value	Adjusted P-value	Odds Ratio	Combined Score	Genes
KEGG_2021_Human	Endometrial cancer	4/58	4.866365645777712e-07	6.131620713679918e-05	98.93827160493827	-213.9782421683718	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Colorectal cancer	4/86	2.39527906270035e-06	0.00015090258095012206	64.92682926829268	-155.35089438097907	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Prostate cancer	4/97	3.882535399026648e-06	0.00016306648675911924	57.168458781362006	-140.4227070470985	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Breast cancer	4/147	2.0304341193526998e-05	0.0005397399433019942	36.946386946386944	-97.65028859286629	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Gastric cancer	4/149	2.14182517183331e-05	0.0005397399433019942	36.42758620689655	-96.46283757609443	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Hepatitis C	4/157	2.633008128708365e-05	0.0005529317070287566	34.4880174291939	-91.97557482769783	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Hepatocellular carcinoma	4/168	3.4380880466544094e-05	0.0006188558483977937	32.13008130081301	-86.4138745753221	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Proteoglycans in cancer	4/205	7.503044944089289e-05	0.0008877785925686614	26.092868988391377	-71.58256188469439	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Non-small cell lung cancer	3/72	7.791014338658423e-05	0.0008877785925686614	49.683229813664596	-92.7008152698569	AKT1;EGFR;TP53
KEGG_2021_Human	Central carbon metabolism in cancer	3/70	7.160249860764975e-05	0.0008877785925686614	51.17910447761194	-94.92366080084827	AKT1;EGFR;TP53
KEGG_2021_Human	Glioma	3/75	8.803803111601103e-05	0.0008877785925686614	47.595238095238095	-89.5568748406007	AKT1;EGFR;TP53
KEGG_2021_Human	Pancreatic cancer	3/76	9.159620399517935e-05	0.0008877785925686614	46.93737769080235	-88.55605413655218	AKT1;EGFR;TP53
KEGG_2021_Human	Melanoma	3/72	7.791014338658423e-05	0.0008877785925686614	49.683229813664596	-92.7008152698569	AKT1;EGFR;TP53
KEGG_2021_Human	Human cytomegalovirus infection	4/225	0.00010785574304042276	0.0009707016873638049	23.671191553544496	-65.36509727839072	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	PD-L1 expression and PD-1 checkpoint pathway in cancer	3/89	0.0001467151296543735	0.0012324070890967376	39.777408637873755	-77.31969343552903	AKT1;CD274;EGFR
KEGG_2021_Human	Thyroid hormone signaling pathway	3/121	0.00036434044298052937	0.002869180988471669	28.87409200968523	-58.78131250266827	AKT1;CTNNB1;TP53
KEGG_2021_Human	Human papillomavirus infection	4/331	0.0004777466484480537	0.0035409457473208686	15.781855249745158	-43.81753827074924	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Fluid shear stress and atherosclerosis	3/139	0.0005476317685268026	0.003833422379687618	24.99579831932773	-51.672386684351224	AKT1;CTNNB1;TP53
KEGG_2021_Human	Thyroid cancer	2/37	0.0008976760152685225	0.005953009364412307	57.378571428571426	-64.24352876962546	CTNNB1;TP53
KEGG_2021_Human	Bladder cancer	2/41	0.001102329014027565	0.00694467278837366	51.467948717948715	-59.107363137308084	EGFR;TP53
KEGG_2021_Human	Kaposi sarcoma-associated herpesvirus infection	3/193	0.0014235649100074823	0.008541389460044894	17.769924812030077	-37.496518500419114	AKT1;CTNNB1;TP53
KEGG_2021_Human	Focal adhesion	3/201	0.0016005928499043844	0.00916703177672511	17.034632034632036	-35.97452728368245	AKT1;CTNNB1;EGFR
KEGG_2021_Human	Rap1 signaling pathway	3/210	0.001815768220475436	0.00994725199043065	16.27536231884058	-34.3854987417392	AKT1;CTNNB1;EGFR
KEGG_2021_Human	Basal cell carcinoma	2/63	0.00258752682682323	0.013584515840821957	32.8155737704918	-41.182346051003734	CTNNB1;TP53
KEGG_2021_Human	Shigellosis	3/246	0.002856466854245349	0.013842877832112077	13.800705467372135	-29.076248648200146	AKT1;EGFR;TP53
KEGG_2021_Human	Pathways in cancer	4/531	0.0028173482711087343	0.013842877832112077	9.539531941808981	-25.060320343159585	AKT1;CTNNB1;EGFR;TP53
KEGG_2021_Human	Adherens junction	2/71	0.0032750085301139972	0.015283373140531988	28.981884057971016	-37.08506032826052	CTNNB1;EGFR
KEGG_2021_Human	Chronic myeloid leukemia	2/76	0.0037436519554145367	0.016846433799365415	27.006756756756758	-34.90410589940028	AKT1;TP53
KEGG_2021_Human	ErbB signaling pathway	2/85	0.004661598778005346	0.01988063772138848	24.051204819277107	-31.541623523071053	AKT1;EGFR
KEGG_2021_Human	MAPK signaling pathway	3/294	0.0047334851717591615	0.01988063772138848	11.45360824742268	-23.841254126382374	AKT1;EGFR;TP53
KEGG_2021_Human	Small cell lung cancer	2/92	0.005440715912052039	0.022113877578017967	22.16111111111111	-29.32328202848766	AKT1;TP53
KEGG_2021_Human	Choline metabolism in cancer	2/98	0.0061532112744065075	0.024228269392975624	20.760416666666668	-27.64199341159925	AKT1;EGFR
KEGG_2021_Human	Longevity regulating pathway	2/102	0.006650847322673755	0.025394144322936157	19.92	-26.61700675496218	AKT1;TP53
KEGG_2021_Human	HIF-1 signaling pathway	2/109	0.007564767477927373	0.028034138300554384	18.600467289719628	-24.98176436194636	AKT1;EGFR
KEGG_2021_Human	PI3K-Akt signaling pathway	3/354	0.007955391465782094	0.028639409276815537	9.422466422466423	-19.140881053489387	AKT1;EGFR;TP53
KEGG_2021_Human	Sphingolipid signaling pathway	2/119	0.008964014539605185	0.03052610356730414	16.98931623931624	-22.939511285821055	AKT1;TP53
KEGG_2021_Human	Neurotrophin signaling pathway	2/119	0.008964014539605185	0.03052610356730414	16.98931623931624	-22.939511285821055	AKT1;TP53
KEGG_2021_Human	Relaxin signaling pathway	2/129	0.010471317399144716	0.03472068400769038	15.631889763779528	-21.1770620526928	AKT1;EGFR
KEGG_2021_Human	FoxO signaling pathway	2/131	0.010785539693571716	0.034845589779231696	15.385658914728682	-20.853034219946885	AKT1;EGFR
KEGG_2021_Human	Estrogen signaling pathway	2/137	0.011753397776716717	0.037023202996657664	14.690740740740742	-19.931093924152265	AKT1;EGFR
KEGG_2021_Human	Measles	2/139	0.012084353093672291	0.03713728023909046	14.472627737226277	-19.639406588988233	AKT1;TP53
KEGG_2021_Human	Signaling pathways regulating pluripotency of stem cells	2/143	0.01275865818396982	0.037385835608841796	14.054964539007091	-19.077689748676264	AKT1;CTNNB1
KEGG_2021_Human	Apoptosis	2/142	0.012588538285001706	0.037385835608841796	14.157142857142857	-19.21549786230027	AKT1;TP53
KEGG_2021_Human	Phospholipase D signaling pathway	2/148	0.0136245920729854	0.03901587729991274	13.565068493150685	-18.413416454449223	AKT1;EGFR
KEGG_2021_Human	Cushing syndrome	2/155	0.014879426053803059	0.04125869824102568	12.933006535947712	-17.54750234216727	CTNNB1;EGFR
KEGG_2021_Human	Cellular senescence	2/156	0.015062699357834773	0.04125869824102568	12.847402597402597	-17.429441058365175	AKT1;TP53
KEGG_2021_Human	Hepatitis B	2/162	0.016183180370760934	0.04248084847324746	12.35625	-16.748364182562245	AKT1;TP53
KEGG_2021_Human	JAK-STAT signaling pathway	2/162	0.016183180370760934	0.04248084847324746	12.35625	-16.748364182562245	AKT1;EGFR
KEGG_2021_Human	Wnt signaling pathway	2/166	0.01694985420863817	0.04358533939364101	12.048780487804878	-16.318740700598067	CTNNB1;TP53
KEGG_2021_Human	Epstein-Barr virus infection	2/202	0.024534595572492535	0.06182718084268119	9.835	-13.147442958027579	AKT1;TP53
KEGG_2021_Human	Lipid and atherosclerosis	2/215	0.027564399546120597	0.06810028123159206	9.219483568075118	-12.240131856521	AKT1;TP53
KEGG_2021_Human	Human T-cell leukemia virus 1 infection	2/219	0.028526440921903908	0.06912176069538255	9.044930875576037	-11.980722307867735	AKT1;TP53
KEGG_2021_Human	Ras signaling pathway	2/232	0.03174764714886429	0.07547553850484719	8.519565217391305	-11.194266119915625	AKT1;EGFR
KEGG_2021_Human	Chemical carcinogenesis	2/239	0.03354092254711208	0.07826215260992819	8.26054852320675	-10.803362590978235	AKT1;EGFR
KEGG_2021_Human	Salmonella infection	2/249	0.03617242514905692	0.08286773761420313	7.915991902834008	-10.280113155611538	AKT1;CTNNB1
KEGG_2021_Human	Ferroptosis	1/41	0.04963848036556211	0.11168658082251474	22.3	-12.692261742471414	TP53
KEGG_2021_Human	MicroRNAs in cancer	2/310	0.0538910819803677	0.1191276549039707	6.298701298701299	-7.775300015246377	EGFR;TP53
KEGG_2021_Human	Carbohydrate digestion and absorption	1/47	0.05671353920929476	0.12320527483398518	19.3768115942029	-11.24402387762608	AKT1
KEGG_2021_Human	Regulation of lipolysis in adipocytes	1/55	0.06607320562588742	0.14110548998070874	16.48971193415638	-9.74227359341278	AKT1
KEGG_2021_Human	VEGF signaling pathway	1/59	0.07072162222736704	0.1485154066774708	15.344827586206897	-9.124402207995153	AKT1
KEGG_2021_Human	Alzheimer disease	2/369	0.07347088540357372	0.15175953378443097	5.2459128065395095	-6.1057863985118	AKT1;CTNNB1
KEGG_2021_Human	Adipocytokine signaling pathway	1/69	0.08225170002715665	0.15229126275181445	13.071895424836601	-7.854937277937848	AKT1
KEGG_2021_Human	Renal cell carcinoma	1/69	0.08225170002715665	0.15229126275181445	13.071895424836601	-7.854937277937848	AKT1
KEGG_2021_Human	Acute myeloid leukemia	1/67	0.07995603885498047	0.15229126275181445	13.47138047138047	-8.082458738692866	AKT1
KEGG_2021_Human	Epithelial cell signaling in Helicobacter pylori infection	1/70	0.08339759626885078	0.15229126275181445	12.880837359098228	-7.74542097629872	EGFR
KEGG_2021_Human	GnRH secretion	1/64	0.07650285602324569	0.15229126275181445	14.11816578483245	-8.446736055993485	AKT1
KEGG_2021_Human	Mitophagy	1/68	0.0811045146521906	0.15229126275181445	13.26865671641791	-7.96724592924887	TP53
KEGG_2021_Human	Fc epsilon RI signaling pathway	1/68	0.0811045146521906	0.15229126275181445	13.26865671641791	-7.96724592924887	AKT1
KEGG_2021_Human	Prolactin signaling pathway	1/70	0.08339759626885078	0.15229126275181445	12.880837359098228	-7.74542097629872	AKT1
KEGG_2021_Human	p53 signaling pathway	1/73	0.0868275630671275	0.15628961352082948	12.339506172839506	-7.43259286356604	TP53
KEGG_2021_Human	Arrhythmogenic right ventricular cardiomyopathy	1/77	0.09138288226635771	0.159920043966126	11.68421052631579	-7.04872976578505	CTNNB1
KEGG_2021_Human	Bacterial invasion of epithelial cells	1/77	0.09138288226635771	0.159920043966126	11.68421052631579	-7.04872976578505	CTNNB1
KEGG_2021_Human	B cell receptor signaling pathway	1/81	0.09591773965141367	0.1655566465216181	11.094444444444445	-6.698191160265787	AKT1
KEGG_2021_Human	Gap junction	1/88	0.10380474953181053	0.1767486275811909	10.192848020434228	-6.152535327455873	EGFR
KEGG_2021_Human	Herpes simplex virus 1 infection	2/498	0.12295964829332588	0.18248134984020342	3.816532258064516	-3.814605004177811	AKT1;TP53
KEGG_2021_Human	GnRH signaling pathway	1/93	0.1094003568916107	0.18248134984020342	9.632850241545894	-5.8073541800756905	EGFR
KEGG_2021_Human	Glucagon signaling pathway	1/107	0.1249011740201087	0.18248134984020342	8.345911949685535	-4.994589105830365	AKT1
KEGG_2021_Human	Insulin resistance	1/108	0.12599902727061665	0.18248134984020342	8.2668743509865	-4.943743954376122	AKT1
KEGG_2021_Human	Melanogenesis	1/101	0.11828795027183354	0.18248134984020342	8.853333333333333	-5.318405524022337	CTNNB1
KEGG_2021_Human	Chagas disease	1/102	0.11939326812281527	0.18248134984020342	8.764576457645765	-5.262086311101535	AKT1
KEGG_2021_Human	C-type lectin receptor signaling pathway	1/104	0.12160016340314761	0.18248134984020342	8.592233009708737	-5.152341092635986	AKT1
KEGG_2021_Human	Fc gamma R-mediated phagocytosis	1/97	0.11385418156418702	0.18248134984020342	9.226851851851851	-5.553951626329874	AKT1
KEGG_2021_Human	AGE-RAGE signaling pathway in diabetic complications	1/100	0.11718138394436346	0.18248134984020342	8.94388327721661	-5.375723879218761	AKT1
KEGG_2021_Human	Parathyroid hormone synthesis, secretion and action	1/106	0.12380207979004104	0.18248134984020342	8.426455026455027	-5.046288872333345	EGFR
KEGG_2021_Human	T cell receptor signaling pathway	1/104	0.12160016340314761	0.18248134984020342	8.592233009708737	-5.152341092635986	AKT1
KEGG_2021_Human	Progesterone-mediated oocyte maturation	1/100	0.11718138394436346	0.18248134984020342	8.94388327721661	-5.375723879218761	AKT1
KEGG_2021_Human	Toll-like receptor signaling pathway	1/104	0.12160016340314761	0.18248134984020342	8.592233009708737	-5.152341092635986	AKT1
KEGG_2021_Human	TNF signaling pathway	1/112	0.13037805537365837	0.18354483122234574	7.964964964964965	-4.748494648054986	AKT1
KEGG_2021_Human	Cholinergic synapse	1/113	0.1314697223892576	0.18354483122234574	7.892857142857143	-4.701617375992292	AKT1
KEGG_2021_Human	Leukocyte transendothelial migration	1/114	0.13256015588280526	0.18354483122234574	7.822025565388397	-4.655477238055189	CTNNB1
KEGG_2021_Human	Toxoplasmosis	1/112	0.13037805537365837	0.18354483122234574	7.964964964964965	-4.748494648054986	AKT1
KEGG_2021_Human	AMPK signaling pathway	1/120	0.13907692219429554	0.18842679781162622	7.4220354808590105	-4.393179099544486	AKT1
KEGG_2021_Human	Growth hormone synthesis, secretion and action	1/119	0.13799386385009413	0.18842679781162622	7.4858757062146895	-4.435243302362896	AKT1
KEGG_2021_Human	Platelet activation	1/124	0.14339691916847833	0.1901895980550344	7.177055103884372	-4.231046804704064	AKT1
KEGG_2021_Human	Cell cycle	1/124	0.14339691916847833	0.1901895980550344	7.177055103884372	-4.231046804704064	TP53
KEGG_2021_Human	Osteoclast differentiation	1/127	0.1466241030974613	0.19244413531541796	7.00352733686067	-4.115510268264927	AKT1
KEGG_2021_Human	Apelin signaling pathway	1/137	0.15730251033809037	0.19623877527326125	6.480392156862745	-3.763669230249352	AKT1
KEGG_2021_Human	Autophagy	1/137	0.15730251033809037	0.19623877527326125	6.480392156862745	-3.763669230249352	AKT1
KEGG_2021_Human	Dopaminergic synapse	1/132	0.1519784338028618	0.19623877527326125	6.73197625106022	-3.9335418472006	AKT1
KEGG_2021_Human	Yersinia infection	1/137	0.15730251033809037	0.19623877527326125	6.480392156862745	-3.763669230249352	AKT1
KEGG_2021_Human	Insulin signaling pathway	1/137	0.15730251033809037	0.19623877527326125	6.480392156862745	-3.763669230249352	AKT1
KEGG_2021_Human	Spinocerebellar ataxia	1/143	0.163651680714637	0.20215795852984572	6.2018779342723	-3.57415842622014	AKT1
KEGG_2021_Human	Cell adhesion molecules	1/148	0.16890973234869874	0.2066274395721946	5.987150415721844	-3.427000500776257	CD274
KEGG_2021_Human	Adrenergic signaling in cardiomyocytes	1/150	0.1710046090025842	0.20717866090697704	5.905294556301268	-3.370661515310376	AKT1
KEGG_2021_Human	Non-alcoholic fatty liver disease	1/155	0.17622102470306392	0.20751260852884162	5.70995670995671	-3.235678410841787	AKT1
KEGG_2021_Human	Oxytocin signaling pathway	1/154	0.17518011116339122	0.20751260852884162	5.74800290486565	-3.2620286219941206	EGFR
KEGG_2021_Human	mTOR signaling pathway	1/154	0.17518011116339122	0.20751260852884162	5.74800290486565	-3.2620286219941206	AKT1
KEGG_2021_Human	Hippo signaling pathway	1/163	0.1845058664849509	0.21525684423244273	5.422496570644719	-3.0356632226338247	CTNNB1
KEGG_2021_Human	cGMP-PKG signaling pathway	1/167	0.1886201000678787	0.21803791383993315	5.289156626506024	-2.942334294710352	AKT1
KEGG_2021_Human	Influenza A	1/172	0.1937366175133076	0.2219164891516069	5.131254061078622	-2.8313674486945275	AKT1
KEGG_2021_Human	Tuberculosis	1/180	0.20186266926868635	0.22914140835904936	4.896958410924891	-2.6658400097237527	AKT1
KEGG_2021_Human	Transcriptional misregulation in cancer	1/192	0.21391358807496763	0.23643080787233264	4.5823152995927865	-2.441961042053517	TP53
KEGG_2021_Human	Neutrophil extracellular trap formation	1/189	0.21091631211370437	0.23643080787233264	4.657210401891253	-2.4954112144854435	AKT1
KEGG_2021_Human	Chemokine signaling pathway	1/192	0.21391358807496763	0.23643080787233264	4.5823152995927865	-2.441961042053517	AKT1
KEGG_2021_Human	Diabetic cardiomyopathy	1/203	0.22481613944093093	0.24419684111687326	4.326732673267327	-2.2588473265567357	AKT1
KEGG_2021_Human	Viral carcinogenesis	1/203	0.22481613944093093	0.24419684111687326	4.326732673267327	-2.2588473265567357	TP53
KEGG_2021_Human	Human immunodeficiency virus 1 infection	1/212	0.23363497492364255	0.251606896071615	4.137440758293839	-2.12256354972075	AKT1
KEGG_2021_Human	Regulation of actin cytoskeleton	1/218	0.2394639268571876	0.25355004020172806	4.019969278033794	-2.037730229066884	EGFR
KEGG_2021_Human	cAMP signaling pathway	1/216	0.23752539179620868	0.25355004020172806	4.058397932816537	-2.065502377074288	AKT1
KEGG_2021_Human	Coronavirus disease	1/232	0.25290994493508406	0.2655554421818383	3.7696007696007694	-1.8563524399324505	EGFR
KEGG_2021_Human	Calcium signaling pathway	1/240	0.2604969587424048	0.2712612958805207	3.6397024639702464	-1.7619943041292825	EGFR
KEGG_2021_Human	Parkinson disease	1/249	0.2689494049142217	0.2777674181900978	3.503584229390681	-1.6629804039719844	TP53
KEGG_2021_Human	Endocytosis	1/252	0.27174750318495006	0.2783754910675098	3.4603806994245243	-1.6315316807371463	EGFR
KEGG_2021_Human	Huntington disease	1/306	0.32049274018188956	0.32566197792675877	2.8280510018214935	-1.1715156192121785	TP53
KEGG_2021_Human	Amyotrophic lateral sclerosis	1/364	0.3695602254440061	0.3725167072475581	2.3584328129782675	-0.8341701676241932	TP53
KEGG_2021_Human	Pathways of neurodegeneration	1/475	0.45466905008847364	0.45466905008847364	1.7801218940459447	-0.4367315309409891	CTNNB1
